Splicing abnormalities have increasingly become more relevant in CLL with the identification of mutations in SF3B1, a splicing factor in a small subset of CLL patients [9] that confer poorer prognosis and can alter RNA splicing patterns. Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.